Researchers provide new insight into human consciousness, reporting we don't consciously choose our feelings or thoughts; we simply become aware of them.
A major finding from researchers at Houston Methodist reveals a significant number of people diagnosed with schizophrenia or bipolar disorder may actually have a treatable immune system disorder. The condition causes NMDA receptors to stop functioning properly and can result in symptoms commonly associated with neuropsychiatric disorders.
University of Edinburgh researchers report many genes linked to neuroticism are also linked to depression. The findings may help to develop more personalized treatments with depressive disorders.
A new study has identified rare genetic variation in the Thorase protein that causes the breakdown of receptors at the connections between neurons in the brain. The anti-epilepsy drug perampanel can help reverse anti-social behaviors linked to schizophrenia that are associated with this genetic variation.
A new study reports different subtypes of bipolar disorder tend to cluster within families, suggesting that even though there are genetic similarities that indicate overlap between subtypes, each has a different origin.
Researchers report brain alterations associated with heightened feelings of negative emotion and alienation in people who have a dependence on cannabis.
Researchers have identified a range of psychiatric disorders, including schizophrenia and autism, that share physical characteristics at the molecular level. Specifically, the study identifies common patterns of neural gene expression. In addition, researchers note important differences in gene expression that distinguish the disorders.
A new study reports caffeine may worsen neuropsychiatric symptoms associated with Alzheimer's disease. Caffeine, researchers report, exacerbates neophobia, anxiety and cognitive flexibility in mouse models of the disease.
A new study builds on previous findings that demonstrate EEG recordings of the rostral anterior cingulate cortex can predict eventual response to treatments for depression.